Brno-based startup Mewery is pursuing a dual-track business model to navigate the high costs of biotechnology. While the company develops cultivated pork using pig umbilical cord cells, it is simultaneously extracting cosmetic molecules from its microalgae biomass to generate immediate revenue.
Leveraging microalgae biomass to bypass meat regulations
Mewery is attempting to solve the "valley of death" problem common in biotech: the long gap between R&D and commercial revenue. As the report notes, the regulatory process for cultivated meat is a decade-long hurdle that can drain capital before a single product reaches a consumer. By purifying its microalgae-based biomass into molecules for cosmetic serums, Mewery can enter a market with fewer permits and faster approval cycles.
This strategy aims to reduce the company's reliance on continuous investor rounds,which have already seen them raise over 100 million Czech koruna from firms like Credo Ventures, Purple Ventures, and Big Idea Ventures. The cosmetics angle is not a side project, but a deliberate financing mechanism to support the core meat-growing platform.
Mewery’s 300g per liter biomass production advantage
The core of Mewery's efficiency lies in a unique cultivation process that combines animal cells with microalgae to provide structure and essential nutrients like antioxidants and fatty acids. According to the report, the company can now extract at least 300 grams of biomass from a single liter of medium. This is a significant leap compared to the roughly 100 grams per liter typically seen in the field.
This high yield supports both the flagship pork burger and the high-value cosmetic extracts that founder Roman Lauš says are difficult to produce synthetically. By maximizing the output of every liter of medium, the company can simultaneously feed its meat R&D and its cosmetics supply chain.
The push for Singapore and EU tasting approvals
Mewery is eyeing Singapore as its first major international market next year due to its faster regulatory approval processes. In the Czech Republic,Roman Lauš expects controlled tastings to be approved by the end of the year, potentially making the country the second in the EU to allow such activities after the Netherlands.
While other companies like France's Gourmey and the Netherlands' Mosa Meat are also navigating European regulations, Mewery's plan involves supplying luxury restaurants in Singapore before attempting a broader rollout in the U.S. and Europe. The company currently estimates that U.S. supply could be possible in about three years.
Scaling toward a €2 per kilogram production cost
To move cultivated pork from a luxury novelty to a staple ingredient, Mewery is focused on aggressive cost reduction through industrial scaling. Currently,the company can reach a cost of €10 per kilogram through its partners. However, the startup aims to bring large-volume production costs down to approximately €2 per kilogram.
If this target is met, Mewery intends to supply ground meat to existing food packaging and distribution businesses rather than building a standalone consumer brand. This approach would lower the marketing burden and allow the company to integrate its cultivated pork into processed meat products more easily.
The mystery of the unnamed foreign production partner
Despite its clear technical roadmap, several critical pieces of Mewery's expansion remain unverified. The company has stated it plans to move bulk production to an unnamed foreign partner before building its own plant in roughly three years, but the identity of this partner and the eventual location of the new facility remain unknown.. Additionally, while the company expects to reach an advanced testing phase for cosmetics next year, the exact timeline for U.S. market entry remains subject to the speed of regulatory shifts in that region.
Comments 0